Health Canada approves Brainsway depression therapy

The company can sell its Deep TMS device, approved last week by the FDA, for the treatment of depression in Canada.

Brainsway Ltd. (TASE:BRIN) has obtained approval from Health Canada for its Deep TMS (transcranial magnetic stimulation) device for the treatment of depression in patients for whom therapeutics have not improved their condition.

Earlier this month, the US Food and Drug Administration (FDA) approved the Deep TMS device for the treatment of depression in patients for whom therapeutics have not improved their condition.

Published by Globes [online], Israel business news - www.globes-online.com - on January 15, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
MORE FROM GLOBES
Twitter Facebook Linkedin RSS Newsletters גלובס